Home › NDC Lookup › RxCUI directory › RxCUI 2671579

Sodium citrate 460 MG Powder for Oral Solution [Emetrol Powder] — RxCUI 2671579

RxNorm drug concept · Semantic branded drug
RxCUI 2671579 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2671579
Official nameSodium citrate 460 MG Powder for Oral Solution [Emetrol Powder]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEmetrol Powder 460 MG Powder for Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Sodium citrate 460 MG Powder for Oral Solution [... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sodium citrate 460 MG Powder for Oral Solution [Emetrol Powder] RxCUI 2671579

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sodium citrate 56466
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Emetrol Powder 2671574
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sodium citrate Powder for Oral Solution 2671572
    • Sodium citrate Oral Powder Product 2671571
    • Sodium citrate Oral Product 1159676
    • Sodium citrate Powder for Oral Solution [Emetrol Powder] 2671578
    • Emetrol Powder Oral Powder Product 2671577
    • Emetrol Powder Oral Product 2671576
    • Powder for Oral Solution 1540455
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium citrate 460 MG Powder for Oral Solution SCD · 2671573
  • Sodium citrate 460 MG SCDC · 2671570
  • Sodium citrate Powder for Oral Solution SCDF · 2671572
  • Sodium citrate Oral Powder Product SCDG · 2671571
  • Sodium citrate Oral Product SCDG · 1159676

Brand-Name Concepts

  • Sodium citrate 460 MG [Emetrol Powder] SBDC · 2671575
  • Sodium citrate Powder for Oral Solution [Emetrol Powder] SBDF · 2671578
  • Emetrol Powder Oral Powder Product SBDG · 2671577
  • Emetrol Powder Oral Product SBDG · 2671576
  • Emetrol Powder BN · 2671574

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2671579 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65197-0203-09 6 POWDER, FOR SOLUTION in 1 CARTON (65197-203-09) Emetrol Powder Non-Drowsy WellSpring Pharmaceutical Corporation 2023-12-01
Observed labelers: WellSpring Pharmaceutical Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.